You are in the Superconductor Week website archive.

Visit the new website by clicking here.

Please be sure to update your bookmarks.

 

   home    search    subscribe    contact    


Superconductor Week

 

 

Thank you to
THE MEADOW
for the stunning
flowers delivered

weekly to our office!

 

New Release -- Superconductor Week does not edit or endorse the following news release:

Intermagnetics Reports Record Revenues, Earnings

Latham, NY, July 27: Intermagnetics General Corporation (Nasdaq: IMGC), today reported that fourth-quarter normalized net income increased to $8.1 million, or $0.29 per diluted share-excluding acquisition and integration-related expenses and certain other non-cash items. Reported net income for the quarter ended May 29, 2005, was $3.4 million, or $0.12 per diluted share. Fourth-quarter net sales were $78.1 million, compared with $52.4 million in the fiscal 2004 fourth quarter, excluding discontinued operations from the divested Polycold subsidiary.

Fiscal 2005 normalized net income before items rose to $29.7 million, or $1.06 per diluted share including partial-year contributions from Polycold. Reported net income in fiscal 2005 was $37.5 million, or $1.34 per diluted share. Reported net sales for the year rose to a record $264.8 million excluding Polycold sales.

(See attached tables for reconciliations to normalized operating results excluding acquisition- and integration-related expenses and other non-cash items and for reconciliations of operations with, and without, Polycold contributions. These tables are included to better assist readers in understanding the company's quarterly and annual performance.)

"All of our business segments, both historical and those acquired in 2004, continued to deliver exceptional performance, resulting in not only a record year, but also setting the stage for a redefined Intermagnetics going forward," said Glenn H. Epstein, chairman and chief executive officer. "Integration of the acquired businesses is complete, and our attention now turns to focus on continuous improvement and sustained growth.

"Our new Medical Devices business segment has exceeded original expectations with opportunities for continued gains. When combined with the new product introduction schedules from our MRI magnet business, we have high confidence for another record performance during our upcoming fiscal year."

Epstein also noted Intermagnetics' balance sheet strength. "During the year, our strong cash flow and proceeds from the Polycold sale enabled us to pay down the majority of the 'revolving' portion of our existing $130 million credit facility, leaving less than $20 million in long-term debt, down from about $112 million following the acquisitions in 2004," Epstein said. "Our expectations for FY2006 are for continued improvements in free cash flow, net of increased capital investments, including the expansion of our MRI magnet manufacturing facility.

"As a result, our interest expense has been reduced dramatically, our cash balances should build fairly rapidly, and we expect that we will remain in an even stronger financial position to pursue a range of strategic initiatives that will further contribute to Intermagnetics' long-term growth."

All Business Segments Deliver Strong Results

Epstein said that all of the company's continuing business segments had strong fourth quarters and full-year performances.

Magnet systems sales rose more than 25 percent during the quarter to $34.9 million from $27.6 million, with an increase in operating profit approaching 35 percent. Full-year sales increased 25 percent to $118.6 million from $95.2 million, with a nearly 30 percent increase in operating profit.

"Orders for our most recent innovations-high-field 3.0 Tesla magnets and 1.0 Tesla high-field open (HFO) magnets-continue to ramp up and provide a strong platform for continued growth," Epstein said. "As forecast previously, the MRI segment delivered record results, and we are in the process of instituting a multi-stage capital and personnel expansion plan to meet anticipated increases in demand."

Medical Devices sales growth, enhanced primarily by the acquisition of MRI Devices and expansion of direct sales personnel, increased to $40.5 million in the fourth quarter, from $22.9 million. For the year, Medical Devices sales were $135.3 million, up from $38.1 million. Year-to-date results in fiscal 2005 include slightly more than 10 months of MRID operations and a full year of Invivo operations. Fiscal 2004 included four months of Invivo-only operations.

The divested Polycold Systems subsidiary, formerly comprising the Instrumentation segment, contributed $23.4 million in sales for a partial year through February 2005, with operating profits of $6.3 million.

(The attached reconciling table labeled "normalized ongoing operations" depicts company performance during FY2005, excluding the discontinued operations from Polycold and any acquisition-related and non-cash performance- based stock compensation and other charges or benefits of $26.6 million, or $0.95 per diluted share. An additional table representing quarterly performance is also attached in order to assist readers to view "normalized ongoing operations" on a quarterly basis.)

Intermagnetics' Energy Technology subsidiary, SuperPower, Inc., generated fourth-quarter revenue of $2.7 million, compared with $1.9 million the prior year. The company's loss due to investment in SuperPower's operations remained stable at about $2.0 million in both periods.

Year-to-date revenues for SuperPower totaled $10.8 million, up from $6.5 million the prior year. Intermagnetics' operating loss for investment in energy technology initiatives during the year increased to $7.2 million, up from $6.2 million, as the subsidiary ramps efforts to commercialize the manufacture of second-generation (2G) high-temperature superconducting (HTS) wire.

SuperPower is in the major construction and installation phase of the Albany HTS Cable Project, with significant milestones toward the physical demonstration of HTS technology in Niagara Mohawk's power grid scheduled during calendar year 2006. The project is a key component in SuperPower's goal of demonstrating the commercial feasibility of HTS wire and devices designed for the transmission and distribution of electrical power.

Most Key Performance Indicators Exceeded

Epstein said that Intermagnetics' focus on its most rapidly growing and profitable product opportunities, as well as continued cost-control efforts, enabled the company to once again surpass most performance goals on a normalized basis.

For the full year, gross margin was 47 percent, compared with a goal of 45 percent; operating margin was 17 percent, compared with a goal of 15 percent; and sales as a percentage of net operating assets was 51 percent, versus a target of 50 percent. Return on equity was 13 percent versus a target of 15 percent. Working capital efficiency was 18 percent, versus a goal of requiring less than 15 percent. All of these metrics have been calculated net of integration-related expenses.

"While normalized gross margins continue to exceed our previously established goal of 45 percent, we are not going to raise this target at this time," Epstein said. "This conservative posture is due to margins that we have budgeted to produce introductory batches of 1.0T HFO magnets. Our experience leads us to believe that we may be able to move a higher overall average consolidated gross margin target early in calendar 2006."

Forecasting A Record Fiscal 2006, Earnings Growth Outlook Raised

"Based on our strong showing during the recently completed quarter and fiscal year, our successes in integrating the new businesses, rationalizing our existing product lines, expanding our sales force and introducing new products, we expect revenues to increase about 15 percent from ongoing revenues of $265 million this year," Epstein said. "Also, we currently anticipate fiscal 2006 operating earnings per share to increase in excess of 20 percent over this year's normalized $0.95 per share from ongoing operations.

"We continue to expect moderate seasonality in our businesses resulting from typically slower summer months (Q1) and a significant number of globally observed holidays (Q3). The second and fourth quarters are expected to be our strongest reporting periods. We also expect highly favorable year-over-year comparisons for each quarter throughout fiscal 2006.

"Specifically for Q1, we currently envision both sales and earnings to be about 20 percent greater than last year's normalized ongoing levels of $51.5 million and $0.16 per share respectively."

Normalized Operating EPS Reconciliation Information

Normalized operating EPS for FY05 includes partial-year operating results from the divested Polycold subsidiary, but excludes the one-time gain from the sale. It also excludes acquisition-related and non-cash performance-based stock compensation and other charges or benefits.

Acquisition charges related to Invivo were $0.06 for fiscal 2005, with no additional charges during the fourth quarter. No further charges are anticipated.

Charges related to the acquisition of MRI Devices (MRID) have now been finalized at $0.24 for the year with a Q4 charge of $0.12. These charges result primarily from a change in accounting for stock distributed to the MRID employee base by the original owners of MRID prior to acquisition, a write- down of acquired assets (value of MRID name) due to the re-branding of MRID to Invivo Diagnostic Imaging, a discretionary realignment of the Medical Devices segment's management structure under the new president and acceleration of certain product rationalization decisions, including inventory write-downs. The majority of the charges were non-cash. No additional charges are expected during fiscal 2006.

The Polycold divestiture resulted in a $0.69 gain on the sale with $0.02 of charges not attributable to deal costs, all of which were recognized in Q3.

The non-cash charge for Intermagnetics' performance-based restricted stock plan for the year was $3.7 million post-tax, or $0.13 per share ($0.03 recognized in Q1, $0.04 in Q2, $0.02 in Q3 and $0.04 in Q4), based on the closing stock price on May 27, 2005. Performance criteria for these restricted stock units was fulfilled based on independently audited financials and was authorized by Intermagnetics' compensation committee of the board of directors to be converted into common stock effective July 25, 2005.

Also excluded is a non-cash gain of $0.03 resulting from a favorable adjustment to an environmental reserve recognized in Q1.

Operating EPS for fiscal 2006 will exclude the estimated non-cash charge for performance-based restricted stock that is currently expected to vest if forecast performance is achieved. A current estimate for the non-cash charge, based on the closing stock price on July 26, 2005, is $6.2 million post-tax, or approximately $0.21 per share.

Return to industry news releases

"Superconductor Week
has a three-fold mission:
to advance the goals of our readers by a critical perspective on low- and high- Tc superconductors and cryogenics; to promote the industry by spreading information and insight to the broadest possible audience; and to provide
a platform for the free exchange of ideas and news within the superconductivity community."

-- Mark Bitterman 
Executive Editor 

NEW:  SCAlert!
Free News
e-
Bulletin
sign up here.

 

Superconductor Week

Subscribe

Back Issues

Special Offers!

Reports Archive

Request Brochure

 

About the Newsletter

About Us

Press Releases

Contact Us

 

Submit News Item

Submit Story Request

 

 
 
 Copyright © 2004 Superconductor Week    -    Last modified: 09/20/07